5-(4-chlorophenyl)-3-(methylthio)-1H-pyrazole

ID: ALA5282295

Max Phase: Preclinical

Molecular Formula: C10H9ClN2S

Molecular Weight: 224.72

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CSc1cc(-c2ccc(Cl)cc2)[nH]n1

Standard InChI:  InChI=1S/C10H9ClN2S/c1-14-10-6-9(12-13-10)7-2-4-8(11)5-3-7/h2-6H,1H3,(H,12,13)

Standard InChI Key:  NMFILWCOJGTBKF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
   18.9467   -4.4326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9455   -5.2521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6536   -5.6611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3633   -5.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3604   -4.4290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6518   -4.0237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2375   -5.6602    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   21.0644   -4.0194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8121   -4.3489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3567   -3.7396    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9454   -3.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1467   -3.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2749   -2.2856    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.0873   -2.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  5  8  1  0
 11 13  1  0
 13 14  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5282295

    ---

Associated Targets(Human)

TRPM8 Tclin Transient receptor potential cation channel subfamily M member 8 (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 224.72Molecular Weight (Monoisotopic): 224.0175AlogP: 3.45#Rotatable Bonds: 2
Polar Surface Area: 28.68Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.43CX Basic pKa: 1.90CX LogP: 3.67CX LogD: 3.67
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.79Np Likeness Score: -1.59

References

1. Bianchini G, Tomassetti M, Lillini S, Sirico A, Bovolenta S, Za L, Liberati C, Novelli R, Aramini A..  (2021)  Discovery of Novel TRPM8 Blockers Suitable for the Treatment of Somatic and Ocular Painful Conditions: A Journey through pKa and LogD Modulation.,  64  (22): [PMID:34762442] [10.1021/acs.jmedchem.1c01647]

Source